{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:04:44Z","timestamp":1781071484439,"version":"3.54.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective hemostatic management remained a critical challenge in neonatal and infant cardiac surgery with cardiopulmonary bypass (CPB), and a systematic review and network meta-analysis (NMA) had not been conducted to evaluate optimal strategy selection for this vulnerable population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Web of Science, Cochrane Library, and Embase from inception to December 3, 2025. We use bivariate analysis and NMA with random effects. We use the surface beneath the cumulative ranking curve (SUCRA) to display the order of interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 8,280 records screened, 27 studies involving 4,556 patients were included. Aprotinin (APR) was identified as the optimal hemostatic strategy for reducing 24-hour blood loss (SUCRA=99.15%), platelet (PLT) (SUCRA=82.19%) and fresh frozen plasma (FFP) (SUCRA=84.82%) transfusion requirements, re-sternotomy for hemostasis (SUCRA=72.85%), and risks of thrombosis (SUCRA=79.13%) and renal dysfunction (SUCRA=72.61%). \u03b5-aminocaproic acid (EACA) was found to be the most effective strategy for reducing red blood cell (RBC) transfusion needs (SUCRA=69.04%). Tranexamic acid (TXA) emerged as the optimal intervention for reducing mortality (SUCRA=84.77%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Antifibrinolytic agents may demonstrated significant hemostatic efficacy and a generally acceptable safety profile in neonatal and infant cardiac surgery with CPB. Among these agents, while APR showed the highest efficacy, its use is constrained by regulatory restrictions and evidence limitations; therefore, it should be used with caution. TXA remains a practical first-line alternative. In the available network, blood component therapies did not emerge as consistently superior strategies compared with other hemostatic interventions. For 24-hour blood loss, APR was associated with lower blood loss than FFP, FC, and PCC. However, because the relevant comparisons were largely against active comparators rather than placebo or no hemostatic intervention, the efficacy of blood component therapies relative to no blood component therapy remains uncertain. Future large-scale RCTs are needed to further validate these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1823450","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:41:50Z","timestamp":1781070110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing hemostasis to prevent bleeding and reduce transfusion requirements in neonatal and infant cardiac surgery with cardiopulmonary bypass: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiali","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, West China Hospital\/West China School of Nursing, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s12872-020-01781-x","article-title":"Global prevalence of congenital heart disease in school-age children: a meta-analysis and systematic review","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/clc.24018","article-title":"Analysis of perioperative corticosteroid therapy in children undergoing cardiac surgery: a systematic review and meta-analysis","volume":"46","author":"Chen","year":"2023","journal-title":"Clin Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11886-024-02022-9","article-title":"Understanding the genetic and non-genetic interconnections in the aetiology of isolated congenital heart disease: an updated review: part 1","volume":"26","author":"Maddhesiya","year":"2024","journal-title":"Curr Cardiol Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0172","DOI":"10.1097\/cce.0000000000000172","article-title":"The use of hemostatic blood products in children following cardiopulmonary bypass and associated outcomes","volume":"2","author":"Closson","year":"2020","journal-title":"Crit Care Explor"},{"key":"B5","doi-asserted-by":"publisher","first-page":"I-iii","DOI":"10.21470\/1678-9741-2018-0605","article-title":"Is the cardiopulmonary bypass systemic inflammatory response overestimated?","volume":"33","author":"Evora","year":"2018","journal-title":"Braz J Cardiovasc Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1055\/s-2007-1000373","article-title":"Coagulation testing in pediatric patients: the young are not just miniature adults","volume":"33","author":"Lippi","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1111\/jth.12372","article-title":"Developmental hemostasis: age-specific differences in the levels of hemostatic proteins","volume":"11","author":"Attard","year":"2013","journal-title":"J Thromb Haemost"},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/00000539-199907000-00011","article-title":"Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery","volume":"89","author":"Williams","year":"1999","journal-title":"Anesth Analg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1097\/pcc.0000000000003049","article-title":"Prophylactic use of antifibrinolytics during pediatric cardiac surgery with cardiopulmonary bypass on postoperative bleeding and transfusion: a systematic review and meta-analysis","volume":"23","author":"Schertz","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"689623","DOI":"10.3389\/fcvm.2021.689623","article-title":"Blood conservation and hemostasis management in pediatric cardiac surgery","volume":"8","author":"Sebastian","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e5798","DOI":"10.1136\/bmj.e5798","article-title":"Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies","volume":"345","author":"Hutton","year":"2012","journal-title":"Br Med J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"110654","DOI":"10.1016\/j.jclinane.2022.110654","article-title":"A review of European guidelines for patient blood management with a particular emphasis on antifibrinolytic drug administration for cardiac surgery","volume":"78","author":"Klein","year":"2022","journal-title":"J Clin Anesth"},{"key":"B13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/eja.0000000000001710","article-title":"Use and safety of aprotinin in routine clinical practice: a European postauthorisation safety study conducted in patients undergoing cardiac surgery","volume":"39","author":"De Hert","year":"2022","journal-title":"Eur J Anaesthesiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"ezae001","DOI":"10.1093\/ejcts\/ezae001","article-title":"Use of aprotinin versus tranexamic acid in cardiac surgery patients with high-risk for excessive bleeding (APACHE) trial: a multicentre retrospective comparative non-randomized historical study","volume":"65","author":"Gallo","year":"2024","journal-title":"Eur J Cardiothorac Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1213\/ane.0000000000005458","article-title":"Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-multicenter randomized controlled trial","volume":"133","author":"Zarbock","year":"2021","journal-title":"Anesth Analg"},{"key":"B16","year":""},{"key":"B17","year":"2012"},{"key":"B18","doi-asserted-by":"publisher","first-page":"CD001886","DOI":"10.1002\/14651858.CD001886.pub3","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","volume":"19","author":"Henry","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/trf.16880","article-title":"Analyzing real world data of blood transfusion adverse events: opportunities and challenges","volume":"62","author":"Jhaveri","year":"2022","journal-title":"Transfusion"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1053\/j.jvca.2024.03.011","article-title":"Methodologic quality and pharmacotherapy recommendations for patient blood management guidelines for cardiac surgery on cardiopulmonary bypass","volume":"38","author":"Huang","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11239-023-02905-8","article-title":"The effects of tranexamic acid on platelets in patients undergoing cardiac surgery: a systematic review and meta-analysis","volume":"57","author":"Zou","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/eja.0000000000001632","article-title":"Efficacy and safety of aprotinin in paediatric cardiac surgery: a systematic review and meta-analysis","volume":"39","author":"Atasever","year":"2022","journal-title":"Eur J Anaesthesiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1213\/ane.0000000000005760","article-title":"Antifibrinolytic drugs for the prevention of bleeding in pediatric cardiac surgery on cardiopulmonary bypass: a systematic review and meta-analysis","volume":"134","author":"Siemens","year":"2022","journal-title":"Anesth Analg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1177\/02676591241298822","article-title":"Postoperative bleeding outcome of fresh frozen plasma prime in pediatric cardiac surgery: a systematic review & meta-analysis","volume":"40","author":"Kesumarini","year":"2025","journal-title":"Perfusion"},{"key":"B25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","article-title":"Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1167","article-title":"Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis","volume":"7","author":"van Valkenhoef","year":"2016","journal-title":"Res Synth Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/bja\/aes002","article-title":"Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery","volume":"108","author":"Bojan","year":"2012","journal-title":"Br J Anaesth"},{"key":"B30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejcts.2008.09.038","article-title":"The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery","volume":"35","author":"Breuer","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/ejcts\/ezy483","article-title":"Recombinant activated factor VII in neonatal cardiac surgery","volume":"55","author":"Christoff","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0003-4975(96)01031-4","article-title":"Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations","volume":"63","author":"Davies","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1213\/ane.0000000000004384","article-title":"Fibrinogen concentrate as an alternative to cryoprecipitate in a postcardiopulmonary transfusion algorithm in infants undergoing cardiac surgery: a prospective randomized controlled trial","volume":"130","author":"Downey","year":"2020","journal-title":"Anesth Analg"},{"key":"B34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1213\/ane.0000000000007123","article-title":"Effect of in vivo administration of fibrinogen concentrate versus cryoprecipitate on ex vivo clot degradation in neonates undergoing cardiac surgery","volume":"141","author":"Downey","year":"2025","journal-title":"Anesth Analg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.mbc.0000233369.03358.c1","article-title":"Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy","volume":"17","author":"Ekert","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/1089253220924504","volume":"24","year":"2020","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"B37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s00246-013-0760-y","article-title":"Use of confidex to control perioperative bleeding in pediatric heart surgery: prospective cohort study","volume":"35","author":"Giorni","year":"2014","journal-title":"Pediatr Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jtcvs.2011.08.051","article-title":"Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery","volume":"143","author":"Graham","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1213\/ane.0b013e318194007a","article-title":"The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis","volume":"108","author":"Guzzetta","year":"","journal-title":"Anesth Analg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3349\/ymj.2013.54.3.752","article-title":"Fresh frozen plasma in pump priming for congenital heart surgery: evaluation of effects on postoperative coagulation profiles using a fibrinogen assay and rotational thromboelastometry","volume":"54","author":"Lee","year":"2013","journal-title":"Yonsei Med J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0126514","DOI":"10.1371\/journal.pone.0126514","article-title":"The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/bja\/aer267","article-title":"Switch from aprotinin to \u03b5-aminocaproic acid: impact on blood loss, transfusion, and clinical outcome in neonates undergoing cardiac surgery","volume":"107","author":"Martin","year":"","journal-title":"Br J Anaesth"},{"key":"B43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1055\/s-0030-1250645","article-title":"Comparison of blood-sparing efficacy of \u03b5-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery","volume":"59","author":"Martin","year":"","journal-title":"Thorac Cardiovasc Surg"},{"key":"B44","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.athoracsur.2003.09.030","article-title":"Fresh frozen plasma in the pediatric pump prime: a prospective, randomized trial","volume":"77","author":"McCall","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/s0003-4975(02)04412-0","article-title":"High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery","volume":"75","author":"M\u00f6ssinger","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1213\/ane.0b013e31817f8b2c","article-title":"The efficacy of aprotinin in arterial switch operations in infants","volume":"107","author":"Murugesan","year":"2008","journal-title":"Anesth Analg"},{"key":"B47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1213\/ane.0000000000006294","article-title":"Activated 4-factor prothrombin complex concentrate as a hemostatic adjunct for neonatal cardiac surgery: a propensity score-matched cohort study","volume":"136","author":"Navaratnam","year":"2023","journal-title":"Anesth Analg"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/s0003-4975(02)04991-3","article-title":"Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime","volume":"75","author":"Oliver","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00246-024-03559-w","article-title":"Effects of fibrinogen concentrate supplementation on postoperative bleeding in infants undergoing Complex cardiac surgery","volume":"46","author":"Rizza","year":"2025","journal-title":"Pediatr Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jclinane.2013.10.015","article-title":"Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery","volume":"26","author":"Scott","year":"2014","journal-title":"J Clin Anesth"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e009465","DOI":"10.1161\/circinterventions.120.009465","article-title":"Individualized, intraoperative dosing of fibrinogen concentrate for the prevention of bleeding in neonatal and infant cardiac surgery using cardiopulmonary bypass (FIBCON): a phase 1b\/2a randomized controlled trial","volume":"13","author":"Siemens","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1007\/s00246-022-02866-4","article-title":"A randomized pilot trial assessing the role of human fibrinogen concentrate in decreasing cryoprecipitate use and blood loss in infants undergoing cardiopulmonary bypass","volume":"43","author":"Tirotta","year":"2022","journal-title":"Pediatr Cardiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1053\/j.jvca.2024.01.021","article-title":"Fresh frozen plasma versus solvent detergent plasma for cardiopulmonary bypass priming in neonates and infants undergoing cardiac surgery: a retrospective cohort study","volume":"38","author":"van Minnen","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B54","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/pan.13473","article-title":"Substitution of artificial colloids for fresh frozen plasma in pediatric cardiopulmonary bypass surgery","volume":"28","author":"Wang","year":"2018","journal-title":"Paediatr Anaesth"},{"key":"B55","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1460-9592.2008.02678.x","article-title":"A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery","volume":"18","author":"Williams","year":"2008","journal-title":"Paediatr Anaesth"},{"key":"B56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1460-9592.2008.02905.x","article-title":"Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass","volume":"19","author":"Guzzetta","year":"","journal-title":"Paediatr Anaesth"},{"key":"B57","first-page":"842","article-title":"In Vivo effects of fibrinogen concentrate (FC) versus cryoprecipitate on the neonatal fibrin network structure after cardiopulmonary bypass (CPB)","volume":"134","author":"Downey","year":"2022","journal-title":"Anesth Analg"},{"key":"B58","doi-asserted-by":"publisher","first-page":"ezae352","DOI":"10.1093\/ejcts\/ezae352","article-title":"2024 EACTS\/EACTAIC guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP","volume":"67","author":"Casselman","year":"2025","journal-title":"Eur J Cardiothorac Surg"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1213\/ane.0000000000004355","article-title":"Society of cardiovascular anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients","volume":"129","author":"Raphael","year":"2019","journal-title":"Anesth Analg"},{"key":"B60","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/s0003-4975(97)01345-3","article-title":"Activation of coagulation and fibrinolysis during cardiothoracic operations","volume":"65","author":"Hunt","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1213\/ane.0b013e3181679555","article-title":"Antifibrinolytic therapy in surgery for congenital heart disease","volume":"106","author":"Eaton","year":"2008","journal-title":"Anesth Analg"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00134-004-2388-0","article-title":"Coagulation disorders of cardiopulmonary bypass: a review","volume":"30","author":"Paparella","year":"2004","journal-title":"Intensive Care Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/eja.0000000000002081","article-title":"Platelet-sparing properties of aprotinin: a scoping review on mechanisms and clinical effects","volume":"42","author":"Vanglabeke","year":"2025","journal-title":"Eur J Anaesthesiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1213\/01.ane.0000194954.64293.61","article-title":"Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin","volume":"102","author":"Arnold","year":"2006","journal-title":"Anesth Analg"},{"key":"B65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1056\/NEJMoa051379","article-title":"The risk associated with aprotinin in cardiac surgery","volume":"354","author":"Mangano","year":"2006","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5114\/kitp.2024.141154","article-title":"Systematic review and meta-analysis of tranexamic acid and epsilon aminocaproic acid in pediatric heart surgery","volume":"21","author":"Szarpak","year":"2024","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12871-019-0772-0","article-title":"Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials","volume":"19","author":"Guo","year":"2019","journal-title":"BMC Anesthesiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1055\/s-0044-1791233","article-title":"Clinical outcomes with high- versus low-dose tranexamic acid infusion in patients undergoing cardiac surgery: a systematic review and meta-analysis","volume":"73","author":"Rangwala","year":"2025","journal-title":"Thorac Cardiovasc Surg"},{"key":"B69","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/ta.0000000000004773","article-title":"The use of tranexamic acid in the management of injured patients at risk of hemorrhage: a systematic review and meta-analysis and an eastern association for the surgery of trauma practice management guideline","volume":"99","author":"Dumas","year":"2025","journal-title":"J Trauma Acute Care Surg"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1823450\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:41:52Z","timestamp":1781070112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1823450\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":69,"alternative-id":["10.3389\/fped.2026.1823450"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1823450","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1823450"}}